Vanda Pharmaceuticals
VNDA
#7458
Rank
C$0.55 B
Marketcap
C$9.39
Share price
-2.57%
Change (1 day)
35.90%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2024 the company made an earning of -C$55.98 Million a decrease over its 2023 earnings that were of -C$19.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion203.24%
2024 -C$55.98 Million191.43%
2023 -C$19.21 Million-320.45%
2022 C$8.71 M-84.99%
2021 C$58.04 M54.8%
2020 C$37.49 M19.42%
2019 C$31.4 M4.93%
2018 C$29.92 M-228.6%
2017 -C$23.27 Million-8.98%
2016 -C$25.57 Million-53.79%
2015 -C$55.32 Million-30.18%
2014 -C$79.24 Million173.08%
2013 -C$29.02 Million-25.33%
2012 -C$38.86 Million163.61%
2011 -C$14.74 Million-221.15%
2010 C$12.16 M-124.53%
2009 -C$49.61 Million-29.44%
2008 -C$70.3 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$90.46 Million170.55%
2005 -C$33.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.59 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.51 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$16.31 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.97 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.78 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.05 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.87 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA